CN103041291B - Traditional Chinese medicine for treating lung cancer - Google Patents
Traditional Chinese medicine for treating lung cancer Download PDFInfo
- Publication number
- CN103041291B CN103041291B CN201210497695.XA CN201210497695A CN103041291B CN 103041291 B CN103041291 B CN 103041291B CN 201210497695 A CN201210497695 A CN 201210497695A CN 103041291 B CN103041291 B CN 103041291B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- lung cancer
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a traditional Chinese medicine for treating lung cancer. The traditional Chinese medicine comprises the following material components in parts by weight: 1-5 parts of red ginsengs, 1-5 parts of curcuma zedoary, 18-22 parts of bulbus fritillariae cirrhosae, 28-32 parts of Chinese lobelias, 23-27 parts of long-noded pit vipers, 13-17 parts of pangolins, 6-10 parts of platicodon grandiflorum, 8-12 parts of earthworms, 6-10 parts of hulls of water chestnuts, 8-12 parts of moringa oleifera roots, 6-10 parts of rabdosia rubescens, 1-5 parts of white glues and 18-22 parts of centipedes. The formula of the traditional Chinese medicine for treating the lung cancer disclosed by the invention adopts the traditional Chinese medicine for preventing phlegm from forming and stopping coughing, so that the medicine has the advantages of stabilizing pathogenic conditions and improving symptoms, and is good in treatment effect.
Description
technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of Chinese medicine for the treatment of pulmonary carcinoma.
background technology:
Pulmonary carcinoma is a kind of common pulmonary malignant tumour, and its mortality rate accounts for first of cancer mortality.Most pulmonary carcinoma originates from bronchial mucosa epithelium, in recent years, along with the impact of smoking and various environmental factorss, countries in the world are industrially developed country particularly, the sickness rate of pulmonary carcinoma and case fatality rate all rise rapidly, die from pulmonary carcinoma in the male patient of carninomatosis and rank first.
The traditional Chinese medical science is thought, the generation of cancer is many by due to QI and blood phlegm-fire, < < miscellaneous diseases source and course rhinoceros candle > > points out, " evil long-pending obstructing airway in the heart, gas must not lead to, for expectorant is blood; pathogen conflicting with vital QIs all; heresy wins, and just must not make it, contraryly forms shape and has piece ".Illustrate that pathogen attacks lung, tie in the heart, impairment of dispersing and descending function of the lung, body fluid is cloth not, poly-ly forms expectorant, and phlegm and qi stasis, blocks lung network, expectorant and the congestion knot of mutually fighting, formation lump, consequently becomes cancer.
Modern medicine mainly adopts the methods such as operation, radiation and chemotherapy to primary disease, excision is a kind of of curative effect the best in various Therapeutic Method, yet, about 80% lung cancer patient when making a definite diagnosis without surgical condition, in operable 20% case, five year survival rate also will decline, and the later stage also will recur, and five year survival rate is very low.
summary of the invention:
The object of the invention is exactly in order to make up the defect of prior art, and a kind of Chinese medicine for the treatment of pulmonary carcinoma is provided, and it has the stable state of an illness to patients with lung cancer, improves the advantage of symptom.
The present invention is achieved by the following technical solutions:
A Chinese medicine for the treatment of pulmonary carcinoma, is characterized in that: the weight proportion of its each raw material components is: Radix Ginseng Rubra 1-5, Rhizoma Curcumae 1-5, Bulbus Fritillariae Cirrhosae 18-22, Herba Lobeliae Chinensis 28-32, Agkistrodon 23-27, Squama Manis 13-17, Radix Platycodonis 6-10, Pheretima 8-12, Shell of Water Chestnut 6-10, Moringa root 8-12, Rabdosia rubescens 6-10, Resina Liquidambaris 1-5, Scolopendra 18-22.
A Chinese medicine for the treatment of pulmonary carcinoma, is characterized in that: the weight proportion of its each raw material components is: Radix Ginseng Rubra 3, Rhizoma Curcumae 3, Bulbus Fritillariae Cirrhosae 20, Herba Lobeliae Chinensis 30, Agkistrodon 25, Squama Manis 15, Radix Platycodonis 8, Pheretima 10, Shell of Water Chestnut 8, Moringa root 10, Rabdosia rubescens 8, Resina Liquidambaris 3, Scolopendra 20.
Advantage of the present invention is:
The present invention fills a prescription and adopts the Chinese medicine of preventing phlegm from forming and stopping coughing, and patients with lung cancer is had to the stable state of an illness, improves the advantage of symptom, and therapeutic effect is good.
the specific embodiment:
Treat a Chinese medicine for pulmonary carcinoma, the weight of its each raw material components (g) is: Radix Ginseng Rubra 3, Rhizoma Curcumae 3, Bulbus Fritillariae Cirrhosae 20, Herba Lobeliae Chinensis 30, Agkistrodon 25, Squama Manis 15, Radix Platycodonis 8, Pheretima 10, Shell of Water Chestnut 8, Moringa root 10, Rabdosia rubescens 8, Resina Liquidambaris 3, Scolopendra 20.
The raw material components that takes above corresponding group, according to the routine fashion of decoction, adds water and boil decoction and takes, every day potion, potion is taken at twice.
For proof, the present invention has good curative effect, enumerates model case as follows:
Case one:
Week certain, man, 49 years old.Patient finds that there is lung posterior lobe in December, 2003 a 2CM*3CM lump.After after being diagnosed as pulmonary carcinoma row resection operation, postoperative pathological shows: right lung squamous cell carcinoma.Afterwards again through chemotherapy and radiation repeatedly.When check in February, 2006, find that left lung shifts.Disease is seen: cough uncomfortable in chest, expectorant are few and sticky, time and hemoptysis is out of breath uncomfortable in chest.The few tongue of red tongue, stringy,thready and rapid pulse.The 30 doses of symptoms of taking medicine take a turn for the better, 50 doses of former side's plus-minus following the services.Clinical symptoms all disappears, and through CT examination foci disappearance, follows up a case by regular visits to so far.
Case two:
Model, female, 38 years old.Patient is because of more than feeling of oppression and pain in the chest February, to hospital's CT examination: two lung diffusivities distribute, the granular nodular shadow of foxtail millet.By pathological diagnosis: alveolar cell carcinoma.Through 3 courses for the treatment of of chemotherapy without positive effect.After take 20 doses of symptoms of Chinese medicine of the present invention and take a turn for the better, 50 doses of former side's plus-minus following the services.Clinical symptoms all disappears, and through film making, checks foci disappearance, follows up a case by regular visits to so far.
Case three:
Liu, man, 47 years old.Patient is because of sensation of oppression over the chest with shortness of breath three months, is diagnosed as upper left lung cancer accompanied mediastinal lymph node metastasis to hospital's CT examination.By 3 of the chemotherapy aggravation course for the treatment of.Disease is seen: feeling of oppression and pain in the chest, and dyspnea with shortness of breath, cough expectorant is thin, sputum mixed with blood, pale complexion, purplish tongue has ecchymosis, thready and hesitant pulse.Take 20 doses of symptoms of Chinese medicine of the present invention and be clearly better, 50 doses of former side's plus-minus following the services.Clinical symptoms disappears substantially, through film making inspection focus scope, dwindles.Regularly further consultation, follows up a case by regular visits to so far.
Claims (1)
1. a Chinese medicine for the treatment of pulmonary carcinoma, is characterized in that: the weight proportion of its each raw material components is: Radix Ginseng Rubra 3, Rhizoma Curcumae 3, Bulbus Fritillariae Cirrhosae 20, Herba Lobeliae Chinensis 30, Agkistrodon 25, Squama Manis 15, Radix Platycodonis 8, Pheretima 10, Shell of Water Chestnut 8, Moringa root 10, Rabdosia rubescens 8, Resina Liquidambaris 3, Scolopendra 20.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210497695.XA CN103041291B (en) | 2012-11-29 | 2012-11-29 | Traditional Chinese medicine for treating lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210497695.XA CN103041291B (en) | 2012-11-29 | 2012-11-29 | Traditional Chinese medicine for treating lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103041291A CN103041291A (en) | 2013-04-17 |
| CN103041291B true CN103041291B (en) | 2014-04-09 |
Family
ID=48054302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210497695.XA Expired - Fee Related CN103041291B (en) | 2012-11-29 | 2012-11-29 | Traditional Chinese medicine for treating lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041291B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104800538A (en) * | 2015-05-14 | 2015-07-29 | 奉化科创科技服务有限公司 | Traditional Chinese medicine for treating lung cancer |
| CN105561035A (en) * | 2016-01-13 | 2016-05-11 | 青岛市肿瘤医院 | Traditional Chinese medicine capsules for treating lung cancer and preparation method thereof |
| CN105687405A (en) * | 2016-03-04 | 2016-06-22 | 尹茂祥 | Immune oral liquid for infants |
| CN107961326A (en) * | 2016-10-19 | 2018-04-27 | 南宁多灵生物科技有限公司 | A kind of Chinese medicine composition for treating lung cancer |
| CN107412635A (en) * | 2017-05-22 | 2017-12-01 | 何东良 | A kind of Chinese medicine composition and its preparation for treating lung cancer |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1437977A (en) * | 2003-01-13 | 2003-08-27 | 许新琳 | Medicine for treating lung cancer |
| CN1970063A (en) * | 2005-11-23 | 2007-05-30 | 杨永光 | Tincture series for treating cancer |
| CN102552856A (en) * | 2012-02-16 | 2012-07-11 | 朱良春 | Powder for strengthening body resistance and eliminating tumor, and preparation method and application thereof |
-
2012
- 2012-11-29 CN CN201210497695.XA patent/CN103041291B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1437977A (en) * | 2003-01-13 | 2003-08-27 | 许新琳 | Medicine for treating lung cancer |
| CN1970063A (en) * | 2005-11-23 | 2007-05-30 | 杨永光 | Tincture series for treating cancer |
| CN102552856A (en) * | 2012-02-16 | 2012-07-11 | 朱良春 | Powder for strengthening body resistance and eliminating tumor, and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103041291A (en) | 2013-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041291B (en) | Traditional Chinese medicine for treating lung cancer | |
| WO2012139314A1 (en) | Chinese herbal medicinal composition for treating cancer | |
| CN102671135B (en) | Chinese medicinal composition for treating ovarian cyst, and preparation method thereof | |
| CN103169883B (en) | Traditional Chinese medicine for treating infantile jaundice | |
| CN103041293B (en) | Traditional Chinese medicine decoction for treating yin-deficiency internal-heat type lung cancer | |
| CN103721180B (en) | A kind of Chinese medicine preparation for the treatment of cancerous protuberance | |
| CN104013851B (en) | A kind of Chinese medicine preparation treating tinea pedis | |
| CN102772697A (en) | Traditional Chinese medicine for treating Qi-Yin deficiency-type chronic nephritis | |
| CN102895371B (en) | Traditional Chinese medicine for treating diarrhea type irritable bowel syndrome | |
| CN102698053B (en) | Nacre Chinese herbal preparation for relieving depression and preparation method of same | |
| CN106237056A (en) | A kind of Chinese medicine decoction treating chronic bronchitis | |
| CN104352990A (en) | Pharmaceutical composition for treating thyroid cancer | |
| CN104815092A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation | |
| CN103041109B (en) | Pills for treating lung cancer by using tofieldia divergens | |
| CN103585326A (en) | Traditional Chinese medicine composition for treating wind-warm lung-heat disease | |
| CN103223092B (en) | Traditional Chinese medicine composition used for treating bronchial asthma | |
| CN102836403B (en) | Chinese medicine for treating chronic nephritis by using root of low greenbrier | |
| CN107625839A (en) | It is a kind of to be used to treat Chinese medicine preparation of cervical carcinoma and preparation method thereof | |
| CN105169108A (en) | Traditional Chinese medicine for treating gestational edema with spleen-deficiency syndrome | |
| CN104491122A (en) | Traditional Chinese medicine composition for treating pulmonary heart disease | |
| CN104027427B (en) | A kind of Chinese medicine for the treatment of YinXuXueRe pattern of syndrome preceeded menorrhea | |
| CN102813898B (en) | Traditional Chinese medicine used for treating chronic nephritis by using Tibetan radix astragali | |
| CN104352691A (en) | Traditional Chinese medicine decoction for treating bronchial asthma | |
| CN104623409A (en) | Traditional Chinese medicine composition for treating pulmonary abscess | |
| CN104547190A (en) | Traditional Chinese medicine for treating infantile jaundice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140409 Termination date: 20151129 |